The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease

John T. Patton(Evangel University), Robert A. Baiocchi(The Ohio State University Wexner Medical Center)
Oncotarget
June 12, 2014
Cited by 28


Related Papers